@article{ArgosDandekar1994,
  author    = {Argos, P. and Dandekar, Thomas},
  title     = {Delineating the main chain topology of four-helix bundle proteins using the genetic algorithm and knowledge based on the amino acid sequence alone},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-33807},
  year      = {1994},
  abstract  = {No abstract available},
  subject      = {Proteine},
  language  = {en}
}
@phdthesis{PatinoGonzalez2007,
  author    = {Pati{\~n}o Gonzalez, Edwin},
  title     = {Functional Studies and X-Ray Structure Analysis of Human Interleukin-5 Receptor Alpha and Human Interleukin-5 Complex},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-27319},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2007},
  abstract  = {Interleukin-5 (IL-5) is a member of the hematopoietic class I cytokines and is specifically involved in eosinophil activation. IL-5 plays an important role in disease conditions such as allergic asthma and other hypereosinophilias, which are characterized by highly increased levels of eosinophils in peripheral blood and tissues. The IL-5 receptor is a heterodimer consisting of a binding alpha subunit (IL- 5R\&\#945;) and a common beta subunit (IL-5R\&\#946;). This IL-5R\&\#946; is shared with the IL-3 and GM-CSF receptors. The IL-5R\&\#945; is required for ligand-specific binding, whereas the association of the IL-5R\&\#946; subunit triggers intracellular signal transduction. Previous studies have described the crystallographic structure of human IL-5 (hIL-5), as well as that of the common IL-5R\&\#946; chain (IL-5R\&\#946;c) However, no experimental structural data are yet available for the interaction of the high-affinity IL-5 receptor IL-5R\&\#945; with its ligand IL-5. Therefore, this thesis had the principle objective to gain new insights into the basis of this important agonist-receptor interaction. In particular, data on the recombinant expression, purification and preparation of the binary complex of hIL-5 bound to the receptor ectodomain of hIL-5R\&\#945; are shown, as well as the subsequent crystal structure analysis of the binary ligand-receptor (hIL-5R\&\#945;/hIL-5) complex. Both proteins were expressed in an Escherichia coli expression system, purified to homogeneity, and crystallized. However, since the initial analysis of these crystals did not show any X-ray diffraction, each step of the preparation and crystallization procedure had to be stepwise optimized. Several improvements proved to be crucial for obtaining crystals suitable for structure analysis. A free cysteine residue in the N-terminal domain of the hIL-5R\&\#945; ectodomain protein was mutated to alanine to remove protein heterogeneity. In addition, hIL-5 affinity chromatography of the receptor protein proved to be absolutely crucial for crystal quality. Additive screening using the initial crystallization condition finally yielded crystals of the binary complex, which diffracted to 2.5{\AA} resolution and were suitable for structure analysis. The preliminary structure data demonstrate a new receptor architecture for the IL-5R\&\#945; ligand-binding domain, which has no similarities to other cytokine class I receptor structures known so far. The complex structure demonstrates that the ligand-binding region of human IL-5R\&\#945; is dispersed over all three extracellular domains, and adopts a binding topology in which the cytokine recognition motif (CRM) needs the first Fn-III domain of the human IL-5R\&\#945; to bind the ligand. In a second project, a prokaryotic expression system for murine IL-5 (mIL-5) was established to allow the production of mIL-5 and mIL-5 antagonist that should facilitate functional studies in mice. Since the expression of mIL-5 in E. coli had never been successful so far, a fusion protein system was generated expressing high yields of mIL-5. Chemical cleavage with cyanogen bromide (CNBr) was used to release mIL-5 monomers, which were subsequently purified and refolded. This technique yielded an active murine IL-5 dimer as confirmed by TF-1 cell proliferation assays. The protein was crystallized and the structure of mIL-5 could be determined at 2.5{\AA} resolution. The molecular structure revealed a symmetrical left-handed four helices bundle dimer similar to human IL-5. Analysis of the structure-/function relationship allowed us to design specific mIL-5 antagonist molecules, which are still under examination. Taken together, these findings provide further insights in the IL-5 and IL-5R interaction which may help to further understand and depict this and other cytokine-receptor interactions of similar architecture, e.g. the IL-13 ligand-receptor system. Ultimately, this may represent another piece of puzzle in the attempts to rationally design and engineer novel IL-5-related pharmacological therapeutics.},
  subject      = {Functional Studies},
  language  = {en}
}